Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CELUthis companyCelularity Inc.	$0.73	-0.31×	-0.75×	1.07×	-0.81×	-1859.9%	24.4%	-230.9%	-345.4%	241.0%	-151.1%	-46.6%	-1.07×	-0.45×	-9.08×	0.15×	20.8%	3	-16.24	2	C
ANVSAnnovis Bio, Inc.	$0.90	-2.47×	4.22×	0×	-1.79×	-22.9%	0.0%	0.0%	0.0%	-171.2%	-170.2%	-36.0%	0×	0.68×	0×	5.8×	0.0%	1	-18.04	2	C+
ATNMActinium Pharmaceuticals, Inc.	$1.57	-1.25×	5.42×	471.4×	0.12×	0.8%	100.0%	-40274.4%	-37652.2%	-432.6%	-81.4%	-58.2%	0.22×	1.4×	0×	6.2×	0.0%	4	-8.02	5	S-
TPSTTempest Therapeutics, Inc.	$0.41	-0.45×	1.79×	0×	-0.48×	-172.7%	0.0%	0.0%	0.0%	-393.9%	-179.5%	-225.2%	1.22×	-0.02×	-128.38×	2.5×	0.0%	1	-53.69	2	C
Peer median	—	-1.25×	4.22×	0×	-0.48×	-22.9%	0.0%	0.0%	0.0%	-393.9%	-170.2%	-58.2%	0.22×	0.68×	0×	5.8×	0.0%	1	-18.04	2	—